Korro Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	115	357	383	-	-
Market Cap Growth	-64.03%	-6.96%	-	-	-
Enterprise Value	47	229	578	-	-
Last Close Price	11.17	38.07	47.93	-	-
PS Ratio	14.22	157.04	-	-	-
PB Ratio	1.06	2.22	2.26	-	-
P/TBV Ratio	1.06	2.22	2.26	-	-
EV/Sales Ratio	6.43	100.98	-	-	-
Debt / Equity Ratio	0.45	0.28	0.20	0.05	-
Net Debt / Equity Ratio	-0.58	-0.74	-0.78	-0.80	-0.97
Net Debt / EBITDA Ratio	0.65	1.34	1.64	0.92	3.50
Net Debt / FCF Ratio	0.82	1.52	1.77	0.89	3.24
Asset Turnover	0.04	0.01	-	-	-
Quick Ratio	6.37	8.54	8.53	6.35	23.95
Current Ratio	6.71	8.79	8.87	6.56	24.20
Return on Equity (ROE)	-63.46%	-50.60%	-69.16%	-62.24%	-
Return on Assets (ROA)	-29.16%	-25.65%	-35.77%	-36.63%	-
Return on Capital Employed (ROCE)	-64.30%	-43.50%	-41.80%	-90.70%	-28.90%
Earnings Yield	-84.05%	-23.43%	-21.18%	-	-
FCF Yield	-66.77%	-21.86%	-19.60%	-	-
Buyback Yield / Dilution	-18.78%	-483.30%	-499.32%	94.26%	-

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q